Company Description
NASDAQ Biotechnology Index (Nasdaq: nbi) is a publicly traded company.
nbi stock has declined 100.0% over the past year.
This page provides a comprehensive overview of nbi stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
NASDAQ Biotechnology Index (nbi) stock. Over the past 12 months, the stock has lost 100.0%.
Latest News
NASDAQ Biotechnology Index has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 4 with negative movement. Key topics include earnings. View all nbi news →
SEC Filings
Financial Highlights
Upcoming Events
Options first vesting
RSU vesting and settlement
Options expiration
NASDAQ Biotechnology Index has 3 upcoming scheduled events. The next event, "Options first vesting", is scheduled for January 14, 2027 (in 289 days). 3 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the nbi stock price.